<table width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 11: Summary of Steady-state AUC<sub>24</sub> of Nelfinavir in Pediatric Studies</caption>
<col align="left" span="1" valign="top" width="25%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="10%"></col>
<col align="center" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="30%"></col>
<tbody>
<tr>
<th colspan="1">Protocol number</th>
<th colspan="1">Dosing regimen<linkhtml href="#footnote-1">*</linkhtml>
</th>
<th colspan="1">N<linkhtml href="#footnote-2">†</linkhtml>
</th>
<th colspan="1">Age</th>
<th colspan="1">AUC<sub>24</sub> (mg∙hr/L)<br/>arithmetic mean ± SD</th>
</tr>
<tr>
<td>AG1343-524</td>
<td>20 (19–28) mg/kg TID</td>
<td>14</td>
<td>2–13 years</td>
<td>56.1±29.8</td>
</tr>
<tr>
<td>PACTG-725</td>
<td>55 (48–60) mg/kg BID</td>
<td>6</td>
<td>3–11 years</td>
<td>101.8±56.1</td>
</tr>
<tr>
<td>PENTA 7</td>
<td>40 (34–43) mg/kg TID</td>
<td>4</td>
<td>2–9 months</td>
<td>33.8±8.9</td>
</tr>
<tr>
<td>PENTA 7</td>
<td>75 (55–83) mg/kg BID</td>
<td>12</td>
<td>2–9 months</td>
<td>37.2±19.2</td>
</tr>
<tr>
<td>PACTG-353</td>
<td>40 (14–56) mg/kg BID</td>
<td>10</td>
<td>6 weeks</td>
<td>44.1±27.4</td>
</tr>
<tr>
<td>1 week</td>
<td>45.8±32.1</td>
</tr>
</tbody>
</table>